Developer docs
API playgroundTry for free, no card

Search company profiles

Viasana

Full company profile

uuid005k68x

Namestring
Viasana
Legal namestring
UAB Viasana
Websiteurl
viasana.lt
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Viasana (legal name UAB Viasana) is a privately held pharmaceutical services firm founded in 2005 and headquartered in Vilnius, Lithuania. It operates a representative/agency model, acting as the official Baltic partner for two global specialty pharma principals — medac GmbH (oncology-focused, across all three Baltic States since 2005) and Octapharma AG (plasma-derived medicines, in Lithuania since 2010) — and delivering an integrated suite of services covering regulatory affairs, market access, sales-force, product launches and promotional events, hospital and state tenders, distribution and logistics, pharmacovigilance, and medical-products trade extending into EU and Non-EU markets. Its stated therapeutic focus is haematology, immunology, oncology, rheumatology, and urology, and it holds GDP, EMVO, and NVVO certifications required for EU-grade pharmaceutical distribution and verification.

The company monetizes through a mix of professional-services fees (regulatory, market access, sales-force, pharmacovigilance) and transaction-based revenue from distribution, tender participation, and medical-products trade. Go-to-market is enterprise B2B: sales-led engagement with global pharma companies seeking Baltic market entry, supplemented by long-term partnerships with major wholesalers and pharmacy chains across Lithuania, Latvia, and Estonia. Pricing is quote-based and not publicly disclosed. Operating geographies explicitly cover the three Baltic states plus broader EU and Non-EU trade lanes. The company does not operate a software product, app, or API; its core technology is described as a pharmaceutical distribution and regulatory services platform, with no proprietary software features disclosed. Notable gaps include undisclosed revenue, undisclosed ownership structure, and no disclosed funding history.

Short descriptiontext

Viasana is a Vilnius-based, privately held pharmaceutical services firm that acts as the official Baltic representative for medac GmbH and Octapharma AG, providing regulatory, market access, sales-force, distribution, tender, and pharmacovigilance services to global pharma companies seeking entry into the Baltic States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersVilnius, Lithuania
HQ citystring
Vilnius
HQ countrystring
Lithuania
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical services, regulatory affairs, market access, pharmaceutical distribution, pharmacovigilance services
Industry3 codes
PRIMARYHLAIAJAK
Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIAJAF
Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYBPADAIAI
Health Supply Chain, Procurement & Access to Medicines
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1Regulatory Services
TypeProfessional Services
Description

Provides regulatory services for pharmaceutical product registration and market authorization in Baltic countries

viasana.lt
2Sales-force Services
TypeProfessional Services
Description

Provides sales-force services including launches, workshops, events, and sales promotions for pharmaceutical products

viasana.lt
3Distribution & Logistics
TypeTransaction Fee
Description

Distribution and logistics services for pharmaceutical products in Baltic Countries, EU and Non-EU countries

viasana.lt
4Tender Services
TypeTransaction Fee
Description

Participates in hospital and state tenders for pharmaceutical products

viasana.lt
5Market Access Services
TypeProfessional Services
Description

Market access services for pharmaceutical products in Baltic markets

viasana.lt
6Trade of Medical Products
TypeTransaction Fee
Description

Participates in the trade of medical products in EU and Non-EU countries

viasana.lt
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Viasana provides a full range of regulatory, marketing, sales-force, and distribution services for pharmaceutical products in the Baltic countries (Lithuania, Latvia, and Estonia), with extension to EU and Non-EU markets. As the official Baltic representative for medac GmbH and Octapharma AG, the company handles pharmaceutical product registration, market access, sales promotion, hospital and state tender participation, distribution and logistics, pharmacovigilance, and trade of medical products for global pharmaceutical manufacturers seeking Baltic market entry.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Viasana offers a unified portfolio of pharmaceutical business services rather than a software product platform. The core offering comprises regulatory services, market access facilitation, sales-force services, distribution and logistics, and pharmacovigilance services—all delivered as an integrated suite for pharmaceutical companies seeking to enter or maintain presence in the Baltic States market (Lithuania, Latvia, Estonia). The company acts as the official representative for medac GmbH (since 2005) and Octapharma AG (since 2010), providing these services alongside participation in hospital and state tenders, and facilitating EU/Non-EU medical product trade.

Product and service8 records
1Regulatory Services
CategoryPharmaceutical Regulatory Affairs
Description

Comprehensive regulatory services covering pharmaceutical product registration, approval processes, and compliance management in Baltic countries for pharmaceutical manufacturers seeking market entry.

2Market Access
CategoryPharmaceutical Market Access
Description

Services to facilitate market entry and positioning of pharmaceutical products in the Baltic States market, supporting manufacturers in launching and growing their presence.

3Sales-Force Services
CategoryPharmaceutical Sales Services
Description

Professional sales team services for promoting and selling pharmaceutical products across the Baltic region on behalf of manufacturer partners.

4Launches, Workshops, Events, and Sales Promotions
CategoryPharmaceutical Marketing Services
Description

Organization and execution of pharmaceutical product launches, educational workshops, industry events, and sales promotional activities in the Baltic region.

5Hospital and State Tenders
CategoryPharmaceutical Tender Services
Description

Participation in hospital procurement tenders and government/state pharmaceutical procurement tenders in Baltic countries on behalf of manufacturer partners.

6Distribution and Logistics Services
CategoryPharmaceutical Distribution and Logistics
Description

Comprehensive distribution and logistics services covering Baltic Countries, EU, and Non-EU countries for pharmaceutical products, leveraging wholesaler and pharmacy chain partnerships.

7Pharmacovigilance Services
CategoryPharmaceutical Pharmacovigilance
Description

Adverse reaction monitoring and reporting services ensuring compliance with pharmaceutical safety regulations, including a 24/7 reporting hotline for the Baltic market.

8Medical Products Trading
CategoryMedical Products Trade
Description

Trade of medical products in EU and Non-EU countries, facilitating international pharmaceutical commerce for partner manufacturers.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2010-01-01
Description

Viasana is the official representative of the Swiss company Octapharma AG for Lithuania since 2010. Octapharma is a Swiss company with branches worldwide, specializing in the development and production of medicines made from blood plasma.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2005-01-01
Description

Viasana is the official representative of the German pharmaceutical company medac GmbH for the Baltic States since 2005. medac is a pharmaceutical products manufacturer with one of its main specializations in oncology, well known both in Germany and internationally.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

KRKA is a Slovenian-headquartered generic pharma manufacturer with strong own-distribution presence across CEE including the Baltics. It competes with Viasana's distribution and tender services by handling its own products end-to-end in the region.

TypeBroad incumbent
Description

Stada is a European generics and specialty pharma group with established sales, distribution and marketing infrastructure across CEE including the Baltics. It is a broader incumbent competing for the same pharma shelf space and tender business Viasana serves.

3Sandoz
TypeBroad incumbent
Description

Sandoz is a global generics company with direct sales and distribution across the Baltics. As a large incumbent, it overlaps with Viasana's distribution and tender participation capabilities in the region.

TypeDirect peer
Description

PharmaLex (now part of Cencora/PharmaLex) is a regulatory affairs and pharmacovigilance services provider for pharma companies across Europe. It is directly comparable to Viasana's regulatory and pharmacovigilance service lines, though operating at broader European scale.

TypeOthers
Description

medac is a German specialty pharma company focused on oncology, urology and rheumatology, and is itself a principal/partner of Viasana. It is relevant context as a global pharma firm that could in principle internalize Baltic operations currently delegated to Viasana.

TypeBroad incumbent
Description

IQVIA is a global CRO and pharma services firm offering regulatory, market access, commercial and pharmacovigilance services. It competes with Viasana for outsourced pharma commercialization work, though at significantly larger scale and broader geographic reach.

TypeDirect peer
Description

Ewopharma is a Central and Eastern Europe pharma commercialization partner that provides regulatory, market access, sales-force and distribution services across multiple CEE countries including the Baltics. Like Viasana, it serves as a local representative for international pharma manufacturers and offers a full-service entry model.

TypeRegional player
Description

Tamro is a leading pharmaceutical wholesaler and distribution partner in the Nordics and Baltics, offering distribution, logistics and value-added pharma services. It is a regional peer to Viasana in the Baltics pharma supply chain.

TypeOthers
Description

Octapharma is a Swiss plasma-products manufacturer and Viasana's other anchor principal partner for Lithuania. It is comparable to medac as a global pharma company whose representative mandate model determines Viasana's Lithuanian revenue base.

TypeRegional player
Description

Pharmia is a Nordic and Baltic pharmaceutical distribution and services company operating in Finland, the Baltics and other Nordic countries. It provides distribution, regulatory and pharmacy services comparable to Viasana's Baltic-focused offering, though with greater Nordic emphasis.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Viasana

Pharmaceutical Servicesviasana.lt

Viasana is a Vilnius-based, privately held pharmaceutical services firm that acts as the official Baltic representative for medac GmbH and Octapharma AG, providing regulatory, market access, sales-force, distribution, tender, and pharmacovigilance services to global pharma companies seeking entry into the Baltic States.

What Viasana does

Viasana (legal name UAB Viasana) is a privately held pharmaceutical services firm founded in 2005 and headquartered in Vilnius, Lithuania. It operates a representative/agency model, acting as the official Baltic partner for two global specialty pharma principals — medac GmbH (oncology-focused, across all three Baltic States since 2005) and Octapharma AG (plasma-derived medicines, in Lithuania since 2010) — and delivering an integrated suite of services covering regulatory affairs, market access, sales-force, product launches and promotional events, hospital and state tenders, distribution and logistics, pharmacovigilance, and medical-products trade extending into EU and Non-EU markets. Its stated therapeutic focus is haematology, immunology, oncology, rheumatology, and urology, and it holds GDP, EMVO, and NVVO certifications required for EU-grade pharmaceutical distribution and verification.

The company monetizes through a mix of professional-services fees (regulatory, market access, sales-force, pharmacovigilance) and transaction-based revenue from distribution, tender participation, and medical-products trade. Go-to-market is enterprise B2B: sales-led engagement with global pharma companies seeking Baltic market entry, supplemented by long-term partnerships with major wholesalers and pharmacy chains across Lithuania, Latvia, and Estonia. Pricing is quote-based and not publicly disclosed. Operating geographies explicitly cover the three Baltic states plus broader EU and Non-EU trade lanes. The company does not operate a software product, app, or API; its core technology is described as a pharmaceutical distribution and regulatory services platform, with no proprietary software features disclosed. Notable gaps include undisclosed revenue, undisclosed ownership structure, and no disclosed funding history.

Viasana firmographics

Firmographics
Name
Viasana
Legal name
UAB Viasana
Website
https://viasana.lt
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
1–10 employees
Short description
Viasana is a Vilnius-based, privately held pharmaceutical services firm that acts as the official Baltic representative for medac GmbH and Octapharma AG, providing regulatory, market access, sales-force, distribution, tender, and pharmacovigilance services to global pharma companies seeking entry into the Baltic States.
Ownership category
akta.pro rank

Viasana industry classification

Industry
Product category
Pharmaceutical Services
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAJAK
Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIAJAF
Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYBPADAIAI
Health Supply Chain, Procurement & Access to Medicines

Keywords

  • Pharmaceutical services
  • Regulatory affairs
  • Market access
  • Pharmaceutical distribution
  • Pharmacovigilance services

Where Viasana is headquartered

Location

Headquarters

HQ city
Vilnius
HQ country
Lithuania
HQ region
Europe

Offices1 record

Markets served

Viasana business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Regulatory Services: Provides regulatory services for pharmaceutical product registration and market authorization in Baltic countries
  2. Sales-force Services: Provides sales-force services including launches, workshops, events, and sales promotions for pharmaceutical products
  3. Distribution & Logistics: Distribution and logistics services for pharmaceutical products in Baltic Countries, EU and Non-EU countries
  4. Tender Services: Participates in hospital and state tenders for pharmaceutical products
  5. Market Access Services: Market access services for pharmaceutical products in Baltic markets
  6. Trade of Medical Products: Participates in the trade of medical products in EU and Non-EU countries

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Viasana product offering

Product offering

Core offering

Viasana provides a full range of regulatory, marketing, sales-force, and distribution services for pharmaceutical products in the Baltic countries (Lithuania, Latvia, and Estonia), with extension to EU and Non-EU markets. As the official Baltic representative for medac GmbH and Octapharma AG, the company handles pharmaceutical product registration, market access, sales promotion, hospital and state tender participation, distribution and logistics, pharmacovigilance, and trade of medical products for global pharmaceutical manufacturers seeking Baltic market entry.

Product overview

Viasana offers a unified portfolio of pharmaceutical business services rather than a software product platform. The core offering comprises regulatory services, market access facilitation, sales-force services, distribution and logistics, and pharmacovigilance services—all delivered as an integrated suite for pharmaceutical companies seeking to enter or maintain presence in the Baltic States market (Lithuania, Latvia, Estonia). The company acts as the official representative for medac GmbH (since 2005) and Octapharma AG (since 2010), providing these services alongside participation in hospital and state tenders, and facilitating EU/Non-EU medical product trade.

Differentiator

Problem solved

Functional benefit

Products and services

  • Regulatory Services Comprehensive regulatory services covering pharmaceutical product registration, approval processes, and compliance management in Baltic countries for pharmaceutical manufacturers seeking market entry.
  • Market Access Services to facilitate market entry and positioning of pharmaceutical products in the Baltic States market, supporting manufacturers in launching and growing their presence.
  • Sales-Force Services Professional sales team services for promoting and selling pharmaceutical products across the Baltic region on behalf of manufacturer partners.
  • Launches, Workshops, Events, and Sales Promotions Organization and execution of pharmaceutical product launches, educational workshops, industry events, and sales promotional activities in the Baltic region.
  • Hospital and State Tenders Participation in hospital procurement tenders and government/state pharmaceutical procurement tenders in Baltic countries on behalf of manufacturer partners.
  • Distribution and Logistics Services Comprehensive distribution and logistics services covering Baltic Countries, EU, and Non-EU countries for pharmaceutical products, leveraging wholesaler and pharmacy chain partnerships.
  • Pharmacovigilance Services Adverse reaction monitoring and reporting services ensuring compliance with pharmaceutical safety regulations, including a 24/7 reporting hotline for the Baltic market.
  • Medical Products Trading Trade of medical products in EU and Non-EU countries, facilitating international pharmaceutical commerce for partner manufacturers.

Companies that use Viasana

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles1 record

Viasana technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Viasana partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Octapharma AGcoreStrategic or Co-development Partner · 1 January 2010Viasana is the official representative of the Swiss company Octapharma AG for Lithuania since 2010. Octapharma is a Swiss company with branches worldwide, specializing in the development and production of medicines made from blood plasma.
  • medac GmbHcoreStrategic or Co-development Partner · 1 January 2005Viasana is the official representative of the German pharmaceutical company medac GmbH for the Baltic States since 2005. medac is a pharmaceutical products manufacturer with one of its main specializations in oncology, well known both in Germany and internationally.

Scale indicators4 records

Recent moves6 records

Expansion highlights3 records

Viasana competitors and assessment

Company assessment

Broad incumbents

  • KRKA: KRKA is a Slovenian-headquartered generic pharma manufacturer with strong own-distribution presence across CEE including the Baltics. It competes with Viasana's distribution and tender services by handling its own products end-to-end in the region.
  • Stada Arzneimittel: Stada is a European generics and specialty pharma group with established sales, distribution and marketing infrastructure across CEE including the Baltics. It is a broader incumbent competing for the same pharma shelf space and tender business Viasana serves.
  • Sandoz: Sandoz is a global generics company with direct sales and distribution across the Baltics. As a large incumbent, it overlaps with Viasana's distribution and tender participation capabilities in the region.
  • IQVIA: IQVIA is a global CRO and pharma services firm offering regulatory, market access, commercial and pharmacovigilance services. It competes with Viasana for outsourced pharma commercialization work, though at significantly larger scale and broader geographic reach.

Direct peers

  • PharmaLex: PharmaLex (now part of Cencora/PharmaLex) is a regulatory affairs and pharmacovigilance services provider for pharma companies across Europe. It is directly comparable to Viasana's regulatory and pharmacovigilance service lines, though operating at broader European scale.
  • Ewopharma: Ewopharma is a Central and Eastern Europe pharma commercialization partner that provides regulatory, market access, sales-force and distribution services across multiple CEE countries including the Baltics. Like Viasana, it serves as a local representative for international pharma manufacturers and offers a full-service entry model.

Others

  • medac GmbH: medac is a German specialty pharma company focused on oncology, urology and rheumatology, and is itself a principal/partner of Viasana. It is relevant context as a global pharma firm that could in principle internalize Baltic operations currently delegated to Viasana.
  • Octapharma AG: Octapharma is a Swiss plasma-products manufacturer and Viasana's other anchor principal partner for Lithuania. It is comparable to medac as a global pharma company whose representative mandate model determines Viasana's Lithuanian revenue base.

Regional players

  • Tamro: Tamro is a leading pharmaceutical wholesaler and distribution partner in the Nordics and Baltics, offering distribution, logistics and value-added pharma services. It is a regional peer to Viasana in the Baltics pharma supply chain.
  • Pharmia: Pharmia is a Nordic and Baltic pharmaceutical distribution and services company operating in Finland, the Baltics and other Nordic countries. It provides distribution, regulatory and pharmacy services comparable to Viasana's Baltic-focused offering, though with greater Nordic emphasis.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Viasana social profiles

Digital presence

Viasana compliance and trust

Trust signal

Compliance3 records

Viasana financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Viasana leadership team

Management profile

Number of profiles

Viasana funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Viasana M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Viasana

What does Viasana do?

Viasana provides a full range of regulatory, marketing, sales-force, and distribution services for pharmaceutical products in the Baltic countries (Lithuania, Latvia, and Estonia), with extension to EU and Non-EU markets. As the official Baltic representative for medac GmbH and Octapharma AG, the company handles pharmaceutical product registration, market access, sales promotion, hospital and state tender participation, distribution and logistics, pharmacovigilance, and trade of medical products for global pharmaceutical manufacturers seeking Baltic market entry.

Is Viasana a public or private company?

Viasana is a private company. It is classified as unknown and is currently operating.

When was Viasana founded?

Viasana was founded in 2005. It employs 1 to 10 people.

Where is Viasana based?

Viasana is headquartered in Vilnius, Lithuania, in the Europe region.

How does Viasana make money?

Six revenue lines are on record. Regulatory Services are the primary driver. The others are sales-force Services, distribution & Logistics, tender Services, market Access Services and trade of Medical Products.

Who are Viasana's main competitors?

Broad incumbents on record are KRKA, Stada Arzneimittel, Sandoz and IQVIA. Direct peers are PharmaLex and Ewopharma. Others are medac GmbH and Octapharma AG. Regional players are Tamro and Pharmia.

Does Viasana have an API?

No public API is recorded for Viasana.

What industry is Viasana in?

Viasana's product category is Pharmaceutical Services. Its primary akta.pro industry code is HLAIAJAK, Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers, with a secondary code of HLAIAJAF, Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor). Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales